Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled cyclosporine for lung transplant recipients (CIS002)
NCT00938236Phase 3Terminated
- Sponsor
- APT Pharmaceuticals
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Cyclosporine Inhalation Solution in lung transplantation, sponsored by APT Pharmaceuticals. Started Dec 2009; status: terminated.
02
Drugs
Cyclosporine Inhalation Solution
03
Conditions
lung transplantation
Beyond the preview
Go deeper on NCT00938236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938236.